Last €104.71 EUR
Change Today +0.66 / 0.63%
Volume 5.3K
AMG On Other Exchanges
Symbol
Exchange
Hong Kong
Mexico
NASDAQ GS
Sao Paulo
Frankfurt
As of 9:16 AM 08/27/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for amgen inc (AMG)

Year over year, Amgen Inc. has been able to grow revenues from $16.6B USD to $18.2B USD. Most impressively, the company has been able to reduce the percentage of sales devoted to income tax expense from 3.99% to 1.01%. This was a driver that led to a bottom line growth from $4.3B USD to $5.1B USD.
Currency in
Millions of US Dollars
As of:Dec 31
2010
Dec 31
2011
Reclassified
Dec 31
2012
Reclassified
Dec 31
2013
4 Year
Trend
Revenues14,660.015,295.016,639.018,192.0
Other Revenues393.0287.0626.0484.0
TOTAL REVENUES15,053.015,582.017,265.018,676.0
Cost of Goods Sold2,220.02,643.03,039.03,346.0
GROSS PROFIT12,833.012,939.014,226.015,330.0
Selling General & Admin Expenses, Total3,983.04,499.04,814.05,184.0
R&D Expenses2,894.03,167.03,380.04,083.0
Depreciation & Amortization, Total294.0------
Other Operating Expenses-1.07.06.0--
OTHER OPERATING EXPENSES, TOTAL7,170.07,673.08,200.09,267.0
OPERATING INCOME5,663.05,266.06,026.06,063.0
Interest Expense-604.0-610.0-1,053.0-1,022.0
Interest and Investment Income254.0298.0273.0173.0
NET INTEREST EXPENSE-350.0-312.0-780.0-849.0
Currency Exchange Gains (Loss)32.0-4.080.097.0
EBT, EXCLUDING UNUSUAL ITEMS5,345.04,950.05,326.05,311.0
Merger & Restructuring Charges-118.0-174.0-335.0-71.0
Gain (Loss) on Sale of Investments90.0154.0132.0150.0
Other Unusual Items, Total---780.0-114.0-125.0
Legal Settlements---780.0-64.0-12.0
Other Unusual Items-----31.0-113.0
EBT, INCLUDING UNUSUAL ITEMS5,317.04,150.05,009.05,265.0
Income Tax Expense690.0467.0664.0184.0
Earnings from Continuing Operations4,627.03,683.04,345.05,081.0
NET INCOME4,627.03,683.04,345.05,081.0
NET INCOME TO COMMON INCLUDING EXTRA ITEMS4,627.03,683.04,345.05,081.0
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS4,627.03,683.04,345.05,081.0
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AMG:GR €104.71 EUR +0.66

AMG Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AbbVie Inc $55.75 USD 0.00
AstraZeneca PLC 4,453 GBp -15.00
Bristol-Myers Squibb Co $50.77 USD 0.00
Eli Lilly & Co $62.81 USD 0.00
Novo Nordisk A/S kr259.20 DKK +0.40
View Industry Companies
 

Industry Analysis

AMG

Industry Average

Valuation AMG Industry Range
Price/Earnings 21.0x
Price/Sales 5.4x
Price/Book 4.3x
Price/Cash Flow 20.8x
TEV/Sales 2.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AMGEN INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.